Mobidiag: Hologic makes a multiplex molecular testing move with $795M Mobidiag acquisition

Mobidiag offers multiplex testing, which is the ability to test for multiple pathogens from a single test sample. Hologic said the acquisition will enable the company to enter the acute care test market, which is projected to grow in a post-pandemic world.